Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Qiagen N.V. Common Shares
(NY:
QGEN
)
50.33
+0.16 (+0.32%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Qiagen N.V. Common Shares
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates
September 28, 2021
Via
FinancialNewsMedia
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates
September 14, 2021
Via
FinancialNewsMedia
QIAGEN to Enter the DAX – Germany’s Leading Stock Market Index
September 03, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Reaches Milestone With Its Kits Used to Process More Than Three Billion Biological Samples to Date
August 23, 2021
From
QIAGEN N.V.
Via
Business Wire
Earnings Scheduled For July 29, 2021
↗
July 29, 2021
Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
↗
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
QIAGEN and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detection Solution Based on QIAcuity Digital PCR Technology
August 10, 2021
From
QIAGEN N.V.
Via
Business Wire
Qiagen Inks Companion Diagnostic Development, Technology-Licensing Deal With OncXerna
↗
August 10, 2021
Qiagen NV (NYSE: QGEN) and OncXerna Therapeutics have signed a master agreement to develop a next-generation sequencing (NGS) companion diagnostic for...
Via
Benzinga
QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements
August 09, 2021
From
QIAGEN N.V.
Via
Business Wire
Qiagen's COVID-19 Antigen Test Gets FDA Emergency Use Approval
↗
August 06, 2021
The FDA has granted emergency use authorization (EUA) to Qiagen N.V.'s (NYSE: QGEN) QIAreach SARS CoV-2 Antigen Test. The rapid, portable test can detect...
Via
Benzinga
QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen
August 06, 2021
From
QIAGEN N.V.
Via
Business Wire
3 Must-Own Healthcare Stocks For Your Portfolio
↗
July 31, 2021
Healthcare stocks have had a steady run so far this year, with the industry’s growth prospects—based on ongoing digitization to revolutionize and increase demand—motivating investors. Thus, we believe...
Via
Talk Markets
Qiagen Stock Gains As Non COVID Sales Boosts Q2 Topline, Bottom-line
↗
July 30, 2021
Qiagen N.V. (NYSE: QGEN) reported after the close of the market Thursday that its second-quarter revenues jumped 28% Y/Y as growth in its core product portfolio...
Via
Benzinga
QIAGEN Reports Full Results for Q2 and H1 2021
July 29, 2021
From
QIAGEN N.V.
Via
Business Wire
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
↗
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
↗
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Qiagen Stock Drops After Trimming FY21 Earnings Forecast On Weaker COVID-19 Testing Trends
↗
July 12, 2021
Qiagen NV (NYSE: QGEN) has reported higher-than-expected second-quarter interim earnings but lowered its outlook on weaker demand for COVID-19 tests, sending its...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021
↗
July 14, 2021
Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE:
Via
Benzinga
QIAGEN N.V. Conference Call on July 13 to Discuss Preliminary Q2 2021 Results
July 12, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program
July 12, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s NeuMoDx™ HAdV Quant Assay Secures CE-IVD Certification for Automated Testing to Detect Human Adenovirus Infections
July 08, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN launches the Workflow Configurator to help life science researchers simplify and optimize their laboratory experiments
July 07, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Forms Strategic Alliance With Sysmex Corporation for Global Cancer Companion Diagnostics Development and Commercialization Using NGS and Plasma-Safe-SeqS Technology
July 01, 2021
From
QIAGEN N.V.
Via
Business Wire
Verogen Partners with QIAGEN to Deliver Innovative Solutions for Human Identification Laboratories
June 29, 2021
From
Verogen
Via
Business Wire
QIAGEN Partners with Verogen to Offer Broadest Portfolio for Human Identification, Including Next Generation Sequencing Solutions
June 29, 2021
From
QIAGEN N.V.
Via
Business Wire
Qiagen Launches CRISPR-Specific Products For Gene-Editing Experiments
↗
June 22, 2021
Qiagen NV (NYSE: QGEN) has launched dedicated solutions specific to CRISPR technology used for editing genomes and modifying gene function. QiaPrep&Amp CRISPR...
Via
Benzinga
QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments
June 21, 2021
From
QIAGEN N.V.
Via
Business Wire
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
↗
June 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...
Via
Benzinga
5 Top ETFs With Exposure To Biogen
↗
June 07, 2021
For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021
↗
June 03, 2021
Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
